Design of chemical libraries for screening

Bibliography

• Snider RM, Constantine JW, Lowe JA III, A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 1991;251:435-7
   PubMed Web of Science ®Google Scholar
• Martin EJ, Blaney JM, Siani MA, Measuring diversity: experimental design of combinatorial libraries for drug discovery. J Med Chem 1995;38:1431-6
   PubMed Web of Science ®Google Scholar
• Dixon SL, Villar HO. Bioactive diversity and screening library selection via affinity fingerprinting. J Chem Inf Comput Sci 1998;38:1192-203
   PubMedGoogle Scholar
• Beroza P, Villar HO, Wick MM, Martin GR. Chemoproteomics as a basis for post-genomic drug discovery. Drug Discov Today 2002;7:807-14
   PubMed Web of Science ®Google Scholar
• Xue L, Bajorath J. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Comb Chem High Throughput Screen 2000;3:363-72
   PubMed Web of Science ®Google Scholar
• Bures MG, Martin YC. Computational methods in molecular diversity and combinatorial chemistry. Curr Opin Chem Biol 1998;2:376-80
   PubMed Web of Science ®Google Scholar
• Maldonado AG, Doucet JP, Petitjean M, Fan BT. Molecular similarity and diversity in chemoinformatics: from theory to applications. Mol Div 2006;10:39-79
   PubMed Web of Science ®Google Scholar
• Dixon SL, Villar HO. Investigation of classification methods for the prediction of activity in diverse chemical libraries. J Comput Aided Mol Des 1999;13:533-45
   PubMed Web of Science ®Google Scholar
• Stahl M, Mauser H. Database clustering with a combination of fingerprint and maximum common substructure methods. J Chem Inf Model 2005;45:542-8
   PubMed Web of Science ®Google Scholar
• Böcker A. Toward an improved clustering of large data sets using maximum common substructures and topological fingerprints. J Chem Inf Model 2008;48:2097-107
   PubMed Web of Science ®Google Scholar
• Nicolaou CA, Tamura SY, Kelley BP, Analysis of large screening data sets via adaptively grown phylogenetic-like trees. J Chem Inf Comput Sci 2002;42:1069-79
   PubMedGoogle Scholar
• Medina-Franco JL, Petit J, Maggiora GM. Hierarchical strategy for identifying active chemotype classes in compound databases. Chem Biol Drug Des 2006;67:395-408
   PubMed Web of Science ®Google Scholar
• Reichard GA. SARVision Plus. J Chem Inf Model 2008;48:1287-8
   PubMed Web of Science ®Google Scholar
• Kho R, Hodges JA, Hansen MR, Villar HO. Ring systems in mutagenicity databases. J Med Chem 2005;48:6671-8
   PubMed Web of Science ®Google Scholar
• Snowden M, Green DV. The impact of diversity-based, high-throughput screening on drug discovery: “chance favours the prepared mind”. Curr Opin Drug Discov Devel 2008;11:553-8
   PubMed Web of Science ®Google Scholar
• Rishton GM. Natural products as a robust source of new drugs and drug leads: past successes and present day issues. Am J Cardiol 2008;101:43D-9D
   Web of Science ®Google Scholar
• Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science 2009;325:161-5
   PubMed Web of Science ®Google Scholar
• Nielsen TE, Schreiber SL. Towards the optimal screening collection: a synthesis strategy. Angew Chem Int Ed Engl 2008;47:48-56
   PubMed Web of Science ®Google Scholar
• Shaw JT. Naturally diverse: highlights in versatile synthetic methods enabling target- and diversity-oriented synthesis. Nat Prod Rep 2009;26:(1):11-26
   PubMed Web of Science ®Google Scholar
• Tan DS. Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat Chem Biol 2005;1:74-84
   PubMed Web of Science ®Google Scholar
• Schnur DM. Recent trends in library design: ‘Rational Design’ revisited. Curr Opin Drug Discov Devel 2008;11:375-80
   PubMed Web of Science ®Google Scholar
• Gillet VJ. New directions in library design and analysis. Curr Opin Chem Biol 2008;12:372-8
   PubMed Web of Science ®Google Scholar
• Huwe CM. Synthetic library design. Drug Discov Today 2006;11:763-7
   PubMed Web of Science ®Google Scholar
• Denner P, Schmalowsky J, Prechtl S. High-content analysis in preclinical drug discovery. Comb Chem High Throughput Screen 2008;11:216-30
   PubMed Web of Science ®Google Scholar
• Orry AJW, Abagyan RA, Cavasotto CN. Structure based development of target specific compound libraries. Drug Discov Today 2008;11:261-6
   Web of Science ®Google Scholar
• Phatak SS, Stephan CC, Cavasotto CN. High-throughput and in silico screenings in drug discovery. Expert Opin Drug Discov 2009;4:947-59
   PubMed Web of Science ®Google Scholar
• Jacoby E. Designing compound libraries targeting GPCRs. Ernst Schering Found Symp Proc 2006:93-103
   PubMedGoogle Scholar
• Akritopoulou-Zanze I, Hajduk PJ. Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors. Drug Discov Today 2009;14:291-7
   PubMed Web of Science ®Google Scholar
• Lowrie JF, Delisle RK, Hobbs DW, Diller DJ. The different strategies for designing GPCR and kinase targeted libraries. Comb Chem High Throughput Screen 2004;7:495-510
   PubMed Web of Science ®Google Scholar
• Sem DS, Bertolaet B, Baker B, Systems-based design of bi-ligand inhibitors of oxidoreductases: filling the chemical proteomic toolbox. Chem Biol 2004;11:185-94
   PubMed Web of Science ®Google Scholar
• Ge X, Sem DS. Affinity-based chemical proteomic probe for dehydrogenases: fluorescence and visible binding assays in gels. Anal Biochem 2007;370:171-9
   PubMed Web of Science ®Google Scholar
• Villar HO, Hansen MR. Computational techniques in fragment based drug discovery. Curr Top Med Chem 2007;7:1509-13
   PubMed Web of Science ®Google Scholar
• Congreve M, Chessari G, Tisi D, Woodhead AJ. Recent developments in fragment-based drug discovery. J Med Chem 2008;51:3661-80
   PubMed Web of Science ®Google Scholar
• Morgan XC, Ni S, Miranker DP, Iyer VR. Predicting combinatorial binding of transcription factors to regulatory elements in the human genome by association rule mining. BMC Bioinformatics 2007;8:445
   PubMedGoogle Scholar
• Chen Q, Chen YP. Mining frequent patterns for AMP-activated protein kinase regulation on skeletal muscle. BMC Bioinformatics 2006;7:394
   PubMedGoogle Scholar